Christina Smolke is the founder of Antheia. Antheia has raised $129M in total funding. Latest round: Series C. Based in Menlo Park, CA.
Christina Smolke is the Co-founder and CEO of Antheia, a synthetic biology company focused on commercializing plant-inspired medicines and essential pharmaceutical ingredients. She also serves as an Adjunct Professor at Stanford University. Smolke leads Antheia's efforts to onshore critical drug manufacturing and has brought the company's first product to commercial sale, leveraging her lab's prior work on biosynthesizing medical opiates in yeast.
Full founder directory · Investor directory · Company funding database · Fundraising library